SCHEMBL3828355

SCHEMBL3828355

COc1ccccc1-c1nnc(C(N)=O)o1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.60
KMT2A Q03164 1/20 0.55
ALDH1A1 P00352 4/20 0.52
GLA P06280 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.50
HPGD P15428 2/20 0.50
CTSS P25774 1/20 0.50
CTSK P43235 1/20 0.50
NPC1 O15118 1/20 0.50
THRB P10828 1/20 0.50
MAPK1 P28482 1/20 0.50
RAB9A P51151 1/20 0.50
EGFR P00533 1/20 0.49
SLC9A1 P19634 1/20 0.47
KDM4E B2RXH2 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
HSD17B10 Q99714 1/20 0.47
LMNA P02545 2/20 0.46
TP53 P04637 1/20 0.46
ALOX15 P16050 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3821034 0.81 RAB9A (0.62) IKBKBALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL3826957 0.80 RAB9A (0.50) KMT2AALDH1A1HPGDNPC1THRB
SCHEMBL11615095 0.79 ALDH1A1 (0.58) IKBKBKMT2AALDH1A1GLASMN1; SMN2
SCHEMBL29392031 0.78 EGFR (0.54) IKBKBKMT2AALDH1A1GLASMN1; SMN2
SCHEMBL22471897 0.78 EGFR (0.54) IKBKBKMT2AALDH1A1GLASMN1; SMN2
SCHEMBL31060717 0.77 KMT2A (0.54) IKBKBKMT2AALDH1A1GLASMN1; SMN2
SCHEMBL30370030 0.77 RAB9A (0.44) ALDH1A1SMN1; SMN2HPGDRAB9AKDM4E
SCHEMBL5338382 0.76 NPC1 (0.66) IKBKBKMT2AALDH1A1GLASMN1; SMN2
SCHEMBL13393606 0.76 BRD4 (0.63) KMT2AALDH1A1GLASMN1; SMN2HPGD
SCHEMBL12171732 0.74 NPC1 (0.66) KMT2AALDH1A1SMN1; SMN2HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP claimed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US claimed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF PYGL, GYS2, G6PC1 IKBKB 1573/4885KMT2A 3325/4885ALDH1A1 775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.